GE HealthCare Technologies Inc. - 8-K Filing

GE HealthCare raises full-year 2026 guidance following Q3 revenue growth of 7.2% to $5.5 billion and appointment of new Patient Care Solutions CEO. (Items: 2.02 Results of Operations and Financial Condition, 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $GEHC

Read the full article at SEC EDGAR

Part of the story GE Vernova Shares Decline Following Revised Wind Segment Loss Projections (6 articles)

More Regulatory news